As of May 18
| -0.04 / -0.33%|
The 5 analysts offering 12-month price forecasts for Spero Therapeutics Inc have a median target of 27.00, with a high estimate of 30.00 and a low estimate of 16.00. The median estimate represents a +123.14% increase from the last price of 12.10.
The current consensus among 6 polled investment analysts is to Buy stock in Spero Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.